Walmart Expands LTL Truck Consolidation Program to Enhance Supply Chain Efficiency Global Markets Rally as Iran Peace Progress Boosts Investor Sentiment Warren Buffetts Record Cash Pile and Michael Burrys AI Bubble Warning Market Signals Under Scrutiny Solar Panel Sales Surge as Businesses Seek LongTerm Energy Cost Savings Foreign Portfolio Investors Voice Concerns Over Rupee Depreciation and Dwindling Returns at Hong Kong Conference Wall Street Divided on Paramount Skydance Outlook Amid Industry Uncertainty CODX Q1 2026 Earnings EPS Falls Short of Estimates Stock Surges on Speculative Optimism YELP Q1 2026 Earnings EPS Beats Estimates Stock Rises BBGI Q4 2025 Earnings Deep Loss Reported as Stock Edges Higher Amid Sparse Data ACR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amidst Commercial Real Estate Headwinds Monarch Casino Resort Inc MCRI Q1 2026 Earnings EPS Surges 349 Above Expectations IVF Q3 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 375 Netflix NFLX Holds Near 88 as Consolidation Persists Manhattan Associates MANH Rallies 3 as Stock Approaches Key Resistance Level Huntington Bancshares Preferred Stock HBANL Holds Steady Near Midpoint of Trading Range Diebold Nixdorf Stock Gains 27 as Trading Volume Picks Up Pyrophyte Acquisition Corp II PAII Holds Steady Near 1018 Amid Low Volatility Inflation Reacceleration Extends Beyond Oil and Geopolitical Factors CNBC Analysis Finds Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline NPFD Edges Higher as Investors Steady Holdings Nuveen Variable Rate Preferred Income Fund NPFD Analysis Equinox Gold EQX Gains 286 as Gold Prices Rally Key Resistance at 1321 in Focus CareCloud Preferred Stock CCLDO Holds Steady Near Key Support as Traders Assess Yield Appeal Vera Therapeutics VERA Edges Higher as Stock Tests Resistance Zone Core Scientific Warrants CORZW Gain 216 as Resistance Test Approaches TROOPS Inc TROO Surges Over 6 Testing Key Resistance at 428 Abbott Laboratories ABT Edges Lower Amid Market Consolidation Key Levels in Focus AEON Biopharma Dips 274 as Stock Nears Critical Support at 076